Proton pump inhibitor leaflets: Is there information on deprescribing?
Abstract This study aims to analyze the existence of information about deprescription in the leaflets of proton pump inhibitor (PPI) medications. The leaflets available on the Brazilian Health Regulatory Agency (ANVISA) and Food and Drug Administration (FDA) websites for the following medications we...
Saved in:
Main Authors: | Marcus Vinícius Lopes Campos, Farah Maria Drumond Chequer, Luanna Gabriella Resende da Silva, André Oliveira Baldoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2025-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100805&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
by: V. T. Ivashkin, et al.
Published: (2020-12-01) -
Deprescribing: An umbrella review
by: Japelj Nuša, et al.
Published: (2024-06-01) -
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Development and Validation of Patient Information Leaflet for Schizophrenia
by: C. G. Deepak, et al.
Published: (2025-01-01) -
Change in Symptoms and Mucosal Findings after Proton Pump Inhibitor in Patients with Laryngopharyngeal Reflux
by: Min Woo Park, et al.
Published: (2025-01-01)